Page last updated: 2024-09-05

bms204352 and Stroke

bms204352 has been researched along with Stroke in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boissard, CG; Cook, DA; Dworetzky, SI; Frantz, SW; Gribkoff, VK; Heman, K; Hewawasam, P; Hibbard, JR; Huston, K; Johnson, G; Kinney, GG; Krishnan, BS; Lombardo, LA; Meanwell, NA; Molinoff, PB; Moon, SL; Myers, RA; Ortiz, A; Pajor, L; Pieschl, RL; Post-Munson, DJ; Signor, LJ; Srinivas, N; Starrett, JE; Taber, MT; Thalody, G; Trojnacki, JT; Wiener, H; Yeleswaram, K; Yeola, SW	1
Jensen, BS	1
Mackay, KB	1
Arnold, M; Krishna, R; Pursley, JM; Shah, V; Srinivas, NR; Vachharajani, NN; Yao, M	1

Reviews

2 review(s) available for bms204352 and Stroke

Article	Year
BMS-204352: a potassium channel opener developed for the treatment of stroke. CNS drug reviews, 2002,Winter, Volume: 8, Issue:4 Topics: Animals; Clinical Trials as Topic; Humans; Indoles; Ion Channel Gating; Neuroprotective Agents; Potassium Channels; Stroke; Treatment Outcome	2002
BMS-204352 (Bristol Myers Squibb). Current opinion in investigational drugs (London, England : 2000), 2001, Volume: 2, Issue:6 Topics: Acute Disease; Animals; Clinical Trials as Topic; Contraindications; Humans; Indoles; Neuroprotective Agents; Stroke; Structure-Activity Relationship	2001

Other Studies

2 other study(ies) available for bms204352 and Stroke

Article	Year
Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nature medicine, 2001, Volume: 7, Issue:4 Topics: Animals; Brain; Calcium; Cell Line; CHO Cells; Cricetinae; Disease Models, Animal; Dogs; Glutamic Acid; Humans; In Vitro Techniques; Indoles; Large-Conductance Calcium-Activated Potassium Channels; Male; Patch-Clamp Techniques; Potassium Channels; Potassium Channels, Calcium-Activated; Rats; Rats, Sprague-Dawley; Rats, Wistar; Safety; Stroke; Synaptic Transmission	2001
Disposition of radiolabeled BMS-204352 in rats and dogs. Biopharmaceutics & drug disposition, 2002, Volume: 23, Issue:1 Topics: Administration, Oral; Animals; Biological Availability; Carbon Radioisotopes; Dogs; Indoles; Male; Neuroprotective Agents; Potassium Channels; Rats; Rats, Sprague-Dawley; Stroke	2002

Article

Year

Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels.

Nature medicine, 2001, Volume: 7, Issue:4

Topics: Animals; Brain; Calcium; Cell Line; CHO Cells; Cricetinae; Disease Models, Animal; Dogs; Glutamic Acid; Humans; In Vitro Techniques; Indoles; Large-Conductance Calcium-Activated Potassium Channels; Male; Patch-Clamp Techniques; Potassium Channels; Potassium Channels, Calcium-Activated; Rats; Rats, Sprague-Dawley; Rats, Wistar; Safety; Stroke; Synaptic Transmission

2001

Disposition of radiolabeled BMS-204352 in rats and dogs.

Biopharmaceutics & drug disposition, 2002, Volume: 23, Issue:1

Topics: Administration, Oral; Animals; Biological Availability; Carbon Radioisotopes; Dogs; Indoles; Male; Neuroprotective Agents; Potassium Channels; Rats; Rats, Sprague-Dawley; Stroke

2002